Precigen (PGEN) 2025 Earnings Outlook: What to Watch
As biotech earnings season unfolds, Precigen (PGEN) 2025 earnings take center stage. This guide breaks down what to m...
Reassessing your budget at the right times keeps your finances aligned with life changes. Learn indicators that signal it’s time to review.
17,868 articlesAs biotech earnings season unfolds, Precigen (PGEN) 2025 earnings take center stage. This guide breaks down what to m...
Two 2021 IPOs diverged dramatically. A $1,000 invested at Coinbase and Robinhood would now sit in a stark split betwe...
A little-known international ETF is quietly outperforming the S&P 500 this year, riding a multi-factor strategy and l...
As primary races heat up in May 2026, some campaign staffers tell they are betting on outcomes using private predicti...
Investors are watching Crinetics' Q1 2026 results for clues on milestones, cash runway, and partnerships. This guide ...
Memory chips are fueling a renewed AI stock rally, but Harvard’s Willy Shih cautions that the boom could cool. Here’s...
As investors eye Regal Rexnord’s Q1 2026 earnings, the focus turns to demand momentum, margin discipline, and capital...
Investors are shifting focus from Intel to overlooked chip stocks delivering real cash flow and AI-driven demand, led...
Eli Lilly dominates the GLP-1 space, but competition is heating up from outside and inside its own lineup. This guide...
When top executives trim stakes, investors take note. This article breaks down the meaning behind such moves, with a ...
DoorDash is down about 30% year-to-date as Amazon climbs about 14%, illustrating a widening gap between pure-delivery...
Rising fuel costs in May 2026 are shifting the auto market. As Detroit paused on new EV bets, Chinese manufacturers m...